The Dutch Acute Stroke Trial: prediction of outcome with CT perfusion and CT angiography.

The Dutch Acute Stroke Trial: prediction of outcome with CT perfusion and CT angiography. - DUST

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON36955

Enrollment

1500

Registered

2009-03-03

Start date

2009-05-19

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic infarct stroke

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Acute neurological deficit caused by cerebral ischemia within 9 hours of onset. No known contraindictations against intravenous contrast. Informed consent.

Exclusion criteria

Exclusion criteria: Another diagnosis such as intracerebral hemorrhage, subarachnoid hemorrhage or tumor. Known contrast allergy or renal failure.

Design outcomes

Primary

Measure	Time frame
primary outcome measures will be 90 day outcome measured by modified Rankin Scale (mRS).	—

Secondary

Measure	Time frame
Day 3 outcome (NIHSS and mRS) or earlier at discharge. Vessel recanalization on CTA. Final infarct size. Asymptomatic and symptomatic hemorrhage on CT.	—

Countries

Netherlands

Outcome results